Pharvaris N.V. Files 6-K, Confirms Foreign Private Issuer Status

TL;DR

**Pharvaris N.V. just filed a routine 6-K, confirming its foreign private issuer status and updating its address.**

AI Summary

Pharvaris N.V. (NASDAQ: PHVS) filed a 6-K on February 16, 2024, indicating it is a foreign private issuer submitting reports under Form 20-F. The filing updates its principal executive office to Emmy Noetherweg 2, 2333 BK Leiden, The Netherlands, from its previous J.H. Oortweg 21 address. This administrative filing confirms the company's compliance with SEC reporting requirements for foreign entities.

Why It Matters

This filing is an administrative update, confirming Pharvaris N.V.'s status as a foreign private issuer and its reporting obligations, which is important for investors to understand its regulatory framework.

Risk Assessment

Risk Level: low — This 6-K filing is purely administrative and does not contain any information that would indicate a financial or operational risk to the company.

Key Players & Entities

• Pharvaris N.V. (company) — registrant
• 001-40010 (other) — Commission File Number
• February 2024 (date) — month of report
• Emmy Noetherweg 2, 2333 BK Leiden, The Netherlands (other) — new principal executive office address
• J.H. Oortweg 21, 2333 CH Leiden, The Netherlands (other) — previous business address

FAQ

From the Filing

0000950170-24-016144.txt : 20240216 0000950170-24-016144.hdr.sgml : 20240216 20240216065104 ACCESSION NUMBER: 0000950170-24-016144 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 7 CONFORMED PERIOD OF REPORT: 20240216 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pharvaris N.V. CENTRAL INDEX KEY: 0001830487 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40010 FILM NUMBER: 24645746 BUSINESS ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 BUSINESS PHONE: 31 (0)71 203 6410 MAIL ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: Pharvaris, B.V. DATE OF NAME CHANGE: 20201029 6-K 1 6-k_egm_pr_announcement.htm 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of February 2024 Commission File Number: 001-40010 Pharvaris N.V. (Translation of registrant’s name into English) Emmy Noetherweg 2   2333 BK Leiden   The Netherlands (Address of principal executive office)   Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐   Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐   Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.   PHARVARIS N.V.   On February 16, 2024, Pharvaris N.V. (the “Company”) issued a press release announcing its 2024 extraordinary general meeting of shareholders to be held on March 6, 2024 and made available to its shareholders certain other materials in connection with such meeting. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein. The materials made available to the Company’s shareholders are attached as Exhibits 99.2 and 99.3 hereto and are incorporated by reference herein.   SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.   PHARVARIS N.V.     Date: February 16, 2024 By: /s/ Berndt Modig   Name: Berndt Modig   Title: Chief Executive Officer   EXHIB INDEX   Exhibit No.   Description 99.1   Press Release dated February 16, 2024. 99.2   Convening Notice, including Agenda and Explanatory Notes. 99.3   Voting Proxy. 99.4   Proposed Articles (English translat